Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Short Report: Viking Therapeutics short interest at 5-year high after VK273 data
9d ago
SMR
MLTX
Premium
Weekend Updates
Viking Therapeutics Stock Plummets: What’s Behind the Drop?
10d ago
VKTX
Premium
The Fly
Largest borrow rate increases among liquid names
12d ago
JHX
VOR
Premium
The Fly
Disappointing competitor oral GLP-1 data an opportunity for Terns, says Mizuho
13d ago
LLY
TERN
Premium
The Fly
Unusually active option classes on open August 20th
13d ago
EL
IQ
Premium
The Fly
Viking Therapeutics selloff on weight loss data overdone, says B. Riley
13d ago
LLY
VKTX
Premium
The Fly
Viking Therapeutics weakness ‘overdone,’ says Leerink
14d ago
VKTX
Premium
The Fly
Market ‘overreacting’ to Viking Therapeutics adverse events, says Jefferies
14d ago
VKTX
Premium
Ratings
Viking Therapeutics’ VK2735: Promising Phase 2 Results Highlight Strong Market Potential and Commercial Viability
14d ago
VKTX
Premium
The Fly
Stifel says buy Viking Therapeutics following ‘overreaction’ to Phase 2 outcome
14d ago
VKTX
Premium
Ratings
Viking Therapeutics: Buy Rating Affirmed Amid Promising VK2735 Trial Results and Market Overreaction
14d ago
VKTX
Premium
The Fly
Viking Therapeutics falls -42.6%
14d ago
VKTX
Premium
The Fly
Viking Therapeutics drop may be partially ‘sell the news,’ says H.C. Wainwright
14d ago
LLY
NVO
Premium
Ratings
Positive Buy Rating for Viking Therapeutics Driven by Promising VK2735 Trial Results and Market Potential
14d ago
VKTX
Premium
The Fly
Viking Therapeutics falls -40.1%
14d ago
VKTX
Premium
The Fly
Morning Movers: Nexstar and Tegna jump following merger deal
14d ago
AS
HD
Premium
The Fly
Eli Lilly, Novo Nordisk up 2% each after Viking obesity pill trial results
14d ago
LLY
NVO
Premium
The Fly
Video: Intel, Viking Therapeutics amid early market movers
14d ago
HD
Premium
The Fly
JPMorgan says Viking weight loss drug still offers strong efficacy
14d ago
VKTX
Premium
Company Announcements
Viking Therapeutics Reports Positive Phase 2 Trial Results
14d ago
8K
VKTX
Premium
The Fly
Viking Therapeutics falls 29% to $29.60 after Phase 2 VK2735 test results
14d ago
VKTX
Premium
The Fly
Viking Therapeutics’ VK2735 achieves endpoints in Phase 2 obesity trial
14d ago
VKTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
